Dr. Lucas received her undergraduate degree from Brown University with Honors. She then received her medical degree from Yale University School of Medicine and completed a Howard Hughes Medical Institute Research Fellowship. She subsequently trained in Internal Medicine at NewYork-Presbyterian Hospital/Columbia University where she served as Chief Medical Resident. She remained at Columbia for fellowship training in Gastroenterology, during which time she served as Chief Gastroenterology Fellow and also obtained a Masters Degree in Patient-Oriented Research from the Mailman School of Public Health at Columbia University. She is board certified in Internal Medicine and Gastroenterology.
American Board of Internal Medicine
ScB, Brown University
MD, Yale School of Medicine
MS, Columbia University Mailman School of Public Health
Residency, Internal Medicine
Columbia University College of Physicians & Surgeons
Chief Gastroenterology Fellow, Division of Digestive and Liver Diseases, Columbia University College of Physicians & Surgeons
Full Scholarship for Masters Degree in Patient Oriented Research at Columbia University Mailman School of Public Health
Chief Medical Resident, Department of Medicine, Columbia University College of Physicians & Surgeons
Jay I. Meltzer/Rudin Foundation Medical Ethics Fellow.
Second Annual American Gastroenterological Association Institute Investing in the Future: Promoting Diversity in GI Training
Janet M. Gasgow Memorial Achievement Citation, Yale University School of Medicine
The Dr. Harold H. Lamport Biomedical Research Prize, Yale University School of Medicine
Howard Hughes Medical Institute Research Training Fellowship for Medical Students: Continued Support for Completion of Medical Studies
Farr Award, Yale University Student Research Day
American Society of Hematology Scholar Award
Howard Hughes Medical Institute Research Training Fellowship for Medical Students
Honors in Biological Sciences, Brown University
Lucas AL, Frado LE, Hwang C, Kumar S, Khanna LG, Levinson EJ, Chabot JA, Chung WK, Frucht H. BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts. Cancer 2014 Jul; 120(13).
Matloff J, Lucas AL, Polydorides AD, Itzkowitz SH. Molecular tumor testing for Lynch syndrome in patients with colorectal cancer. Journal of the National Comprehensive Cancer Network 2013 Nov; 11(11).
Lucas AL, Shakya R, Lipsyc MD, Mitchel EB, Kumar S, Hwang C, Deng L, Devoe C, Chabot JA, Szabolcs M, Ludwig T, Chung WK, Frucht H. High prevalence of BRCA1 and BRCA2 germline mutations with loss of heterozygosity in a series of resected pancreatic adenocarcinoma and other neoplastic lesions. Clinical cancer research 2013 Jul; 19(13).
Lucas AL, Chang MM, Lipsyc MD, Frucht H. The prevention and genetics of pancreatic cancer: a programmatic approach. Methods in molecular biology (Clifton, N.J.) 2013; 980.
Lucas AL, Hwang C, Frucht H. Strengthening the case for stool DNA tests as first-line colorectal cancer screening: are we there yet? [review]. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2012 Mar; 10(3).
Amin S, McBride R, Mitchell E, Lucas AL, Neugut A, Frucht H. Incidence of Subsequent Pancreatic Adenocarcinoma in Patients with a History of Nonpancreatic Primary Cancers.. Cancer 2012; 118(5): 1244-51.
Gonda TA, Lucas AL, Saif MW. Screening and detection of pancreatic cancer. Highlights from the [review]. JOP : Journal of the pancreas 2011 Jul; 12(4).
Swaminath A, Lucas AL, Capiak K, Sethi A, Garcia-Carrasquillo R. A foreign body larger than the overtube diameter: a case of a large cow foot bone causing esophageal impaction.. Gastroenterology and Hepatology : 2010; ;6(12): 793-5. .
Lucas A, Petrylak DP. The case for early chemotherapy for the treatment of metastatic disease [review]. The Journal of urology 2006 Dec; 176(6 Pt 2).
Hassid B, Lucas AL, Salomao M, Weng C, Liu F, Khanna LG, Kumar S, Hwang C, Chabot JA, Frucht H. Absence of Pancreatic Intraepithelial Neoplasia (PanIN) Predicts Poor Survival Following Resection of Pancreatic Cancer. [abstract]. Pancreas. 2014;.
Becker AE, Hernandez YG, Frucht H, Lucas AL. Pancreatic Ductal Adenocarcinoma: Risk Factors, Screening and Early Detection.. World J Gastroenterol 2014 August 28; 20(32): 11182.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Lucas has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.